Neurology - McMaster Experts

publication venue for

Amyloid inflammatory myopathy: report of two cases and literature review (P9-8.009) 2023
Association of a ≥2 point decrease of MoCA 1 year after noncardiac surgery with patient-important outcomes: a secondary analysis of the NeuroVISION cohort study (P2-12.001) 2023
Whole Genome Sequencing to Resolve the Genomic Architecture of Cerebral Palsy in a Canadian Cohort (P13-9.003) 2023
"Long-hauler" impact of COVID-19 on brain microstructure: a 3-month follow-up study 2022
Clinical Delineation of Myasthenia Gravis in the Kingdom of Bahrain 2022
Clinical Delineation of Myasthenia Gravis in the Kingdom of Bahrain 2022
Cerebral Microbleeds and Acute Hematoma Characteristics in the ATACH-2 and MISTIE III Trials 2022
A clinical decision tool to evaluate eligibility for endovascular therapy upon transfer within a regional stroke center 2021
The Long-term Functional Recovery Trajectory of Patients with Spontaneous Intracerebral Hemorrhage: A Systematic Review and Meta-analysis 2021
Combination Antithrombotic Treatment for prevention of recurrent Ischemic Stroke in IntraCranial Atherosclerotic Disease: CATIS-ICAD 2020
Cost of Hospitalization for Stroke in a Low-Middle Income Country: Findings from a Public Tertiary Hospital in the Philippines 2020
Evaluation of Staff Communication Before and After Implementation of a Training Protocol for Inpatients with Memory Impairments 2020
Generator Replacement with Cardiac Based VNS Device in Children with Drug-Resistant Epilepsy 2020
Risk Factors for Recurrence of Vascular Events in Middle-Aged Stroke Survivors 2020
The Validity of the National In-training Examination for Canadian Pedatric Neurology Residents (NITECaP) 2020
Racial/ethnic disparities in the risk of intracerebral hemorrhage recurrence 2020
Acute Hyperglycemia is Associated with Larger Antithrombotic-Related Intracerebral Hemorrhage Volume 2018
Characterization of Atrial Fibrillation in Antithrombotic-Related Intracerebral Hemorrhage 2018
Mitochondrial disease phenotypes of 999 patients in the North American Mitochondrial Disease Consortium (NAMDC) 2018
Subclavian Steal Syndrome secondary to Dialysis AVF treated with Balloon Mounted Stent 2018
The development of the National In-training examination for Canadian Pediatric Neurology Residents (NITECaP) 2018
A rare case of CNS involvement with Chronic Lymphocytic Leukemia CLL 2017
Andexanet Alfa for the Management of Acute Major Bleeding Associated with FXa Inhibitors (P5.059) 2017
Self-perceived psychological stress and risk of all-cause mortality after stroke: the Mashhad Stroke Incidence Study (MSIS) 2017
Stroke in women: Results from the Mashhad Stroke Incidence Study (MSIS), a population based study in the Middle-East 2017
Stroke in women: Results from the Mashhad Stroke Incidence Study (MSIS), a population based study in the Middle-East 2017
Rare Cases of Thrombotic and Embolic Strokes with Hypereosinophilia 2017
Dialectical Behaviour Therapy Is an Effective Treament for Depression and Anxiety in Multiple Sclerosis 2016
Dialectical Behaviour Therapy Is an Effective Treatment for Depression and Anxiety in Multiple Sclerosis 2016
Multiple Sclerosis Lesions Show Perturbations in Cerebral Microbiota 2016
Multiple Sclerosis Lesions Show Perturbations in Cerebral Microbiota 2016
Multiple Sclerosis Lesions Show Perturbations in Cerebral Microbiota 2016
Multiple Sclerosis Lesions Show Perturbations in Cerebral Microbiota 2016
Multiple Sclerosis Lesions Show Perturbations in Cerebral Microbiota 2016
Multiple Sclerosis Lesions Show Perturbations in Cerebral Microbiota 2016
Multiple Sclerosis Lesions Show Perturbations in Cerebral Microbiota 2016
Progressive Myoclonus Epilepsy Caused by SACS Mutations 2016
Progressive Myoclonus Epilepsy Caused by SACS Mutations 2016
Stroke Subtypes and Risk Factors in Saudi Arabia 2016
Warfarin-Related Intracerebral Hemorrhage: Predictors of Hematoma Expansion and In-Hospital Mortality 2016
Warfarin-Related Intracerebral Hemorrhage: Predictors of Hematoma Expansion and In-Hospital Mortality 2016
Pharmacokinetic-Pharmacodynamic effects of sublingual apomorphine (APL-130277) for acute rescue of OFF episodes in Parkinson's disease patients 2015
Time-to-INR Reversal, Predictors of Hematoma Expansion and In-hospital Mortality in Warfarin-related Intracerebral Hemorrhage 2015
Left Ventricular Hypertrophy as an Indicator of White Matter Hyperintensities in Young Stroke Patients 2014
A Possible Association between Fluticasone Propionate and Tics in Pediatric Asthmatic Patients: Two Case Reports and a Literature Review 2013
Cerebral Microbleed Burden Predicts Symptomatic Intracerebral Hemorrhage Following Thrombolysis 2013
Cerebral Microbleed Burden Predicts Symptomatic Intracerebral Hemorrhage Following Thrombolysis 2013
Cerebral Microbleeds in Young Stroke Patients 2013
Discharge Outcomes of Ischemic Stroke Patients with Diabetes: Get with the Guidelines 2013
Noninvasive Motor Evoked Potentials with Surface Stimulation in Rodents 2013
Phenotypic Variability in French-Canadian Kindred with Novel Combination of Heterozygous SH3TC2 Mutations 2013
Prevalence and Determinants of White Matter Hyperintensities in Young Stroke Patients 2013
Stroke Rehabilitation: Factors That Predict Return Home 2013
Supratentorial Intraparenchymal Hemorrhage Following Spinal Procedures 2013
The "Good Old Days" Bias in Pediatric Mild Traumatic Brain Injury 2013
The "Good Old Days" Bias in Pediatric Mild Traumatic Brain Injury 2013
The Vascular Topography of Ischemic Stroke in Young Patients 2013
A Phase 2, Randomized, Placebo-Controlled, Multiple Ascending-Dose Study of ACE-031, a Soluble Activin Receptor Type IIB, in Boys with Duchenne Muscular Dystrophy (DMD) (P04.088) 2012
Ex-Vivo Gene Therapy Approach for Continuous Delivery of BDNF and Its Potential Use for Neurological Disorders (P02.013) 2012
Ex-Vivo Gene Therapy Approach for Continuous Delivery of BDNF and Its Potential Use for Neurological Disorders (IN6-1.008) 2012
Cortical Deafness: A Case of Selective Auditory Agnosia, Amusia and Word Deafness 2012
A Randomized, Placebo-Controlled, Multiple-Ascending Dose Study of ACE-031 (ActRIIB-IgG1) in Duchenne Muscular Dystrophy (DMD) 2011
An Autopsy Confirmed Axonal GBS Case after H1N1 Vaccination 2011
As Observational Study Examining Factors Affecting Quality of Life in Subjects Receiving Tysabri and the Effect of Tysabri on Quality of Life in Multiple Sclerosis over 12 Months 2011
Cerebral Microbleeds: Histopathological Correlation of Neuroimaging 2011
Dynamic Endovascular, Vascular and Parenchymal Changes during Adult Ischemic Stroke: A Pilot Study 2011
EEG Patterns in Highly Selective ICU Patients Are Associated with In-Hospital Death 2011
Post-Vaccination Miller Fisher Syndrome 2011
Thrombolysis for Acute Stroke in Hemodialysis Patients: International Survey of Expert Opinion 2011
Curcumin Prevents the Development of Vacuous Chewing Movements in a Preclinical Animal Model of Human Tardive Dyskinesia and Proteomic Array Reveals a Possible Role of Target Proteins in the Mechanism of Action 2010
Declines of Metabotropic Glutamate Receptor in Patients with Early AD: In Vivo Evidence of a Novel Biomarker for Hippocampal Dysfunction 2010
Development and Evaluation of Allosteric Modulators of Dopamine D2 Receptors in Pre-Clinical Rat Models: Implications for the Treatment of Parkinson's Disease and Drug Induced Dyskinesia 2010
Reduced Cerebral Bleeding Rates with Dabigatran Compared to Warfarin in Patients with Atrial Fibrillation: Results of RE-LY 2010
Synthesis and Evaluation of Novel Compounds for the Treatment of Parkinson's Disease 2010
The Boston Driving Screen - Validation of a Clinical Tool for Assessing Driving Problems in the Elderly 2010
Left Ventricular Systolic Dysfunction and the Risk of Stroke in the Cardiovascular Health Study 2009
Stroke in Generation X: Etiology and Clinical Outcome of Stroke in Patients under 45 Years 2009
Cardiovascular fitness and cognition in mild-moderate Parkinson's disease 2008
Escalating levels of access to in-hospital care and stroke mortality 2008
Incentives and barriers of patients and physicians for participating in the National Institute of Neurological Disorders and Stroke (NINDS) Clinical Research Collaboration (CRC) 2007
Stroke mortality: Does hospital volume matter? 2007
Anatomical evidence from stroke patients with hemispatial neglect for dual networks mediating spatial attention 2006
Cholinesterase inhibitors slow decline in function in Alzheimer's Disease (AD): A 2-year observational study in the Sunnybrook dementia cohort 2006
Impaired arterial tone in patients with migraine with aura during headache-free periods 2006
Is self-reported stroke history reliable in elderly with cognitive impairment? A community-based study 2006
Cholinesterase inhibitor treatment slows decline in function and multiple cognitive domains in Alzheimer's disease: A 1-year, prospective study in the Sunnybrook Dementia Cohort 2005
Only spontaneous counterfactual thinking is impaired in patients with frontal lobe lesions 2004
Increased anticardiolipin antibody IgG titers do not predict recurrent stroke or TIA in children 2004
A novel SCO2 mutation (G1521A) presenting as a spinal muscular atrophy phenotype 2002
A novel heteroplasmic mitochondrial complex I gene mutation associated with adult-onset dystonia 2002
Cardiovagal autonomic baroreflex sensitivity impairment in patients with inappropriate sinus tachycardia during orthostatic stress 2002
Oral zolmitriptan exhibits efficacy as early as 30 minutes in menstrually associated migraine: Results of a large multicenter placebo-controlled study 2002
Late onset metachromatic leukodystrophy clinically presenting as isolated peripheral neuropathy: Compound heterozygosity for the IVS2+1G -> A mutation and a newly identified missense mutation (Thr408Ile) in a Spanish family 2001
Clinical indicators of outcome in local intraarterial thrombolysis for acute stroke 2000
Somatosensory extinction of simultaneous bilateral stimuli is associated with decreased activation of contralateral somatosensory cortices: A fMRI study 2000
Symptomatic intracranial hemorrhage after intraarterial thrombolysis with recombinant prourokinase in acute ischemic stroke: The PROACT II study 2000
A novel mitochondrial DNA mutation in a patient with dystonia, stroke like episodes and cataracts 1999
Functional neuroanatomy in the pre-Hippocratic era: Lessons from the Iliad of Homer 1999
Reversible visual impairment from cyclosporine/FK506 induced hypertension 1999
Serum S100 beta and neuron specific enolase (NSE) in acute ischemic stroke 1999
The clinical utility of the forearm ischemic test lactate ammonia response in the diagnosis of neuromuscular disorders: Insights into mitochondrial cytopathies and myoadenylate deaminase deficiency 1999
The neurological complications of left ventricular assist devices 1998
Canine distemper virus and multiple sclerosis 1997
Extrapyramidal side-effects of risperidone 1997
Intravenous immunoglobulin and plasmapheresis as effective treatments of Sydenham's chorea 1996
DIFFERENCES IN STROKE BETWEEN HISPANICS AND NON-HISPANICS 1995
DIFFERENTIAL CONTRIBUTION OF INDEXES OF LEAD DOSE TO NEUROPSYCHOLOGICAL PERFORMANCE 1995
OXYTOCIN IN POSTMORTEM ALZHEIMER BRAIN 1986
SUBSTANCE P-LIKE IMMUNOREACTIVITY IS REDUCED IN CEREBRAL-CORTEX IN ALZHEIMERS-DISEASE 1986
DISTRIBUTION OF HSV TYPE-1 IN THE CENTRAL NERVOUS-SYSTEM - IMMUNOPEROXIDASE STUDY OF HUMAN MENINGOENCEPHALITIS 1981
MELATONIN AND EXPERIMENTAL EPILEPSY 1976
Association of Vascular Risk With Severe vs Non-Severe Stroke: An Analysis of the INTERSTROKE Study.. 103:e210087. 2024
Consent-Related Outcomes in the Alteplase Compared to Tenecteplase Trial.. 103:e209974. 2024
Gene-Gene Interaction Between Factor- XI and ABO Genes in Cerebral Venous Thrombosis. 102:e209445. 2024
Efficacy and Safety of Statins for Secondary Stroke Prevention in Patients With Cerebral Microbleeds. 102:e209261. 2024
Incidence of Stroke in Indigenous Populations of Countries With a Very High Human Development Index. 102:e209138. 2024
Endovascular Thrombectomy in Patients With Very Low ASPECTS Scores. 101:e2043-e2045. 2023
Association Between Hematoma Expansion Severity and Outcome and Its Interaction With Baseline Intracerebral Hemorrhage Volume. 101:e1606-e1613. 2023
Efficacy and Safety of Elamipretide in Individuals With Primary Mitochondrial Myopathy. 101:e238-e252. 2023
To Use Perfusion Imaging or Not in Patient Selection for Late Window Endovascular Thrombectomy?. 100:1039-1040. 2023
Sleep Patterns and the Risk of Acute Stroke. 100:e2191-e2203. 2023
Depressive Symptoms and Risk of Acute Stroke. 100:e1787-e1798. 2023
Global Impact of the COVID-19 Pandemic on Stroke Volumes and Cerebrovascular Events. 100:e408-e421. 2023
Alcohol Intake as a Risk Factor for Acute Stroke. 100:e142-e153. 2023
Contribution of Common Genetic Variants to Risk of Early-Onset Ischemic Stroke. 99:e1738-e1754. 2022
Quantitative Muscle Analysis in FSHD Using Whole-Body Fat-Referenced MRI. 99:e877-e889. 2022
Prolonged Cardiac Monitoring and Stroke Recurrence. 98:e1942-e1952. 2022
Neurological impact of COVID-19: Sub-acute brain microstructural alterations in self-isolated individuals (S18.008). 98. 2022
“Long-hauler” impact of COVID-19 on brain microstructure: a 3-month follow-up study (P1-1.Virtual). 98. 2022
Mitochondrial DNA Copy Number as a Marker and Mediator of Stroke Prognosis. 98:e470-e482. 2022
Blood Pressure After Endovascular Thrombectomy and Outcomes in Patients With Acute Ischemic Stroke. 98:e291-e301. 2022
Effect of Cognitive Reserve on the Association of Vascular Brain Injury With Cognition. 97:e1707-e1716. 2021
Utility of Intravenous Alteplase Prior to Endovascular Stroke Treatment. 97:e777-e784. 2021
Short- and Long-term Health Care Resource Utilization and Costs Following Intracerebral Hemorrhage. 97:e608-e618. 2021
Global Impact of COVID-19 on Stroke Care and IV Thrombolysis. 96:e2824-e2838. 2021
Oral factor Xa inhibitors and risk of subdural hematoma. 95:e480-e487. 2020
Channelopathies are a frequent cause of genetic ataxias associated with cerebellar atrophy (1719). 94. 2020
Evaluation of Staff Communication Before and After Implementation of a Training Protocol for Inpatients with Memory Impairments (2262). 94. 2020
Impact of a National Dementia Research Program – the CCNA (Canadian Consortium on Neurodegeneration in Aging) (2342). 94. 2020
The Vagus Nerve Is Critical for the Rapid and Widespread Response in the Brain Following Oral Administration of a Physiologically Active Bacteria (1556). 94. 2020
Racial/ethnic disparities in the risk of intracerebral hemorrhage recurrence. 94:e314-e322. 2020
APOE and cortical superficial siderosis in CAA. 93:e358-e371. 2019
Aquaporin-4 and MOG autoantibody discovery in idiopathic transverse myelitis epidemiology. 93:e414-e420. 2019
A phase 3 randomized study evaluating sialic acid extended-release for GNE myopathy. 92:e2109-e2117. 2019
Effects of blood pressure and lipid lowering on cognition. 92:e1435-e1446. 2019
Relative effects of LDL-C on ischemic stroke and coronary disease. 92:e1176-e1187. 2019
Serum magnesium and calcium levels in relation to ischemic stroke. 92:e944-e950. 2019
Genetic and lifestyle risk factors for MRI-defined brain infarcts in a population-based setting. 92:e486-e503. 2019
Are lobar microbleeds of diagnostic value in the community?. 92:121-122. 2019
Area postrema syndrome. 91:e1642-e1651. 2018
Incidence of sudden unexpected death in epilepsy in children is similar to adults. 91:e107-e111. 2018
The effect of white matter hyperintensities on verbal memory. 90:e673-e682. 2018
TRMT5 mutations are associated with features of complex hereditary spastic paraparesis. 89:2210-2211. 2017
COL4A2 is associated with lacunar ischemic stroke and deep ICH. 89:1829-1839. 2017
DNA methylation predicts stroke outcome better. 89:758-759. 2017
Early and lethal neurodegeneration with myasthenic and myopathic features. 89:657-664. 2017
Effects of exercise on fitness and health of adults with spinal cord injury. 89:736-745. 2017
Long-term antithrombotic treatment in intracranial hemorrhage survivors with atrial fibrillation. 89:687-696. 2017
Genetically decreased vitamin D and risk of Alzheimer disease. 87:2567-2574. 2016
Child Neurology: Diencephalic syndrome–like presentation of a cervicomedullary brainstem tumor. 87:e248-e251. 2016
Increasing comorbidity and health services utilization in older adults with prior stroke. 87:2091-2098. 2016
Clinical relevance of microbleeds in acute stroke thrombolysis. 87:1534-1541. 2016
Circulating biomarkers and incident ischemic stroke in the Framingham Offspring Study. 87:1206-1211. 2016
Genome-wide meta-analysis of cerebral white matter hyperintensities in patients with stroke. 86:146-153. 2016
Disparities in surgery among patients with intractable epilepsy in a universal health system. 86:72-78. 2016
Pearls & Oy-sters: Spinocerebellar ataxia type 3 presenting with cervical dystonia without ataxia. 86:e1-e3. 2016
Cerebral microbleeds and postthrombolysis intracerebral hemorrhage risk. 85:927-934. 2015
Healthy eating and reduced risk of cognitive decline. 84:2258-2265. 2015
Children's perspective of quality of life in epilepsy. 84:1830-1837. 2015
Cerebral amyloid angiopathy with and without hemorrhage. 84:1206-1212. 2015
Two cases of congenital myasthenic syndrome with vocal cord paralysis. 84:1281-1282. 2015
Inflammatory biomarkers, cerebral microbleeds, and small vessel disease. 84:825-832. 2015
Interrelationship of superficial siderosis and microbleeds in cerebral amyloid angiopathy. 83:1838-1843. 2014
Cerebrovascular reactivity predicts stroke in high-grade carotid artery disease. 83:1424-1431. 2014
Midodrine for orthostatic hypotension and recurrent reflex syncope. 83:1170-1177. 2014
Convulsive status epilepticus and health-related quality of life in children with epilepsy. 83:752-757. 2014
Meta-analysis in more than 17,900 cases of ischemic stroke reveals a novel association at 12q24.12. 83:678-685. 2014
Effects of cannabis on cognition in patients with MS. 82:1879-1887. 2014
Functional Neuroimaging of Sensory Conversion Disorder: The Role of Ancillary Activation (P2.158). 82. 2014
Is There Chronic Brain Damage in Retired NFL Players? Neuroradiology, Neuropsychology and Neurology of 45 Retired Players (I12-1.003). 82. 2014
Is There Chronic Brain Damage in Retired NFL Players? Neuroradiology, Neuropsychology and Neurology of 45 Retired Players (P5.325). 82. 2014
Peroxisomal D-bifunctional protein deficiency. 82:963-968. 2014
Clinical spectrum of SCN2A mutations expanding to Ohtahara syndrome. 81:992-998. 2013
Association of atrial fibrillation with mortality and disability after ischemic stroke. 81:825-832. 2013
Pain assessment using the NIH Toolbox. 80:S49-S53. 2013
A randomized trial of varenicline (chantix) for the treatment of spinocerebellar ataxia type 3. 79:2218-2218. 2012
Estimating treatment effects in observational studies. 79:1844-1845. 2012
Quality of life in children with new-onset epilepsy. 79:1548-1555. 2012
Vitamin D, cognition, and dementia. 79:1397-1405. 2012
Care and outcomes in patients with ischemic stroke with and without preexisting dementia. 77:1664-1673. 2011
Clinical features of facioscapulohumeral muscular dystrophy 2. 75:1548-1554. 2010
Albuminuria and the risk of incident stroke and stroke types in older adults. 75:1343-1350. 2010
Do all ischemic stroke subtypes benefit from organized inpatient stroke care?. 75:456-462. 2010
Impaired interhemispheric inhibition in writer's cramp. 75:441-447. 2010
Risk of premature stroke in recent immigrants (PRESARIO). 74:451-457. 2010
SUBCUTANEOUS IGF-1 IS NOT BENEFICIAL IN 2-YEAR ALS TRIAL. 73:1247-1248. 2009
GASTROINTESTINAL BLEEDING AFTER ACUTE ISCHEMIC STROKE. 73:160-161. 2009
MRI in the diagnosis of pediatric multiple sclerosis. 72:961-967. 2009
Role of MRI in the differentiation of ADEM from MS in children. 72:968-973. 2009
Incidence of acquired demyelination of the CNS in Canadian children. 72:232-239. 2009
Gastrointestinal bleeding after acute ischemic stroke. 71:650-655. 2008
Joint effect of stroke and APOE 4 on dementia risk. 70:9-16. 2008
Long-term prognosis in children with neonatal seizures. 69:1816-1822. 2007
Hospital volume and stroke outcome. 69:1142-1151. 2007
Phase II/III randomized trial of TCH346 in patients with ALS. 69:776-784. 2007
Independent predictors of stroke in patients with atrial fibrillation. 69:546-554. 2007
Seizures during stroke thrombolysis heralding dramatic neurologic recovery. 67:2048-2049. 2006
Unexplained neurologic symptoms: An fMRI study of sensory conversion disorder. 67:2036-2038. 2006
Elevated serum angiogenin levels in ALS. 67:1833-1836. 2006
Thyroid replacement therapy and atrial fibrillation in acute ischemic stroke. 67:1714-1715. 2006
Association of the H63D polymorphism in the hemochromatosis gene with sporadic ALS. 65:934-937. 2005
Adding aspirin to clopidogrel after TIA and ischemic stroke. 64:1117-1121. 2005
A novel candidate region for ALS on chromosome 14q11.2. 63:1936-1938. 2004
A clinical trial of creatine in ALS. 63:1656-1661. 2004
The high risk of stroke immediately after transient ischemic attack. 62:2015-2020. 2004
Creatine monohydrate enhances strength and body composition in Duchenne muscular dystrophy. 62:1771-1777. 2004
Mutation of the slow myosin heavy chain rod domain underlies hyaline body myopathy. 62:1518-1521. 2004
Autosomal dominant hyaline body myopathy. 61:1519-1523. 2003
Modafinil reduces excessive somnolence and enhances mood in patients with myotonic dystrophy. 59:1876-1880. 2002
Adaptation in the motor cortex following cervical spinal cord injury. 58:794-801. 2002
Neuropsychological assessment in children with absence epilepsy. 57:1940-1940. 2001
Beyond the hippocampus. 57:1669-1674. 2001
Bilateral movement enhances ipsilesional cortical activity in acute stroke: A pilot functional MRI study. 57:1740-1741. 2001
Cerebral hemorrhage after intra-arterial thrombolysis for ischemic stroke. 57:1603-1610. 2001
Generalized epilepsy with febrile seizures plus. 57:1191-1198. 2001
Creatine monohydrate does not increase strength in patients with hereditary neuropathy. 57:559-560. 2001
Multifocal motor neuropathy improved by IVIg. 56:1608-1608. 2001
Bilateral movement enhances ipsilesional cortical activity in acute stroke: A pilot functional MRI study. 56:401-404. 2001
Developmental apraxia arising from neonatal brachial plexus palsy. 55:1761-1761. 2000
Monoclonal antibodies against Epstein–Barr virus cross-react with α-synuclein in human brain. 55:1398-1401. 2000
Multifocal motor neuropathy improved by IVIg. 55:1256-1262. 2000
Neurologic side effects in neuroleptic-naïve patients treated with haloperidol or risperidone. 55:1069-1069. 2000
Developmental apraxia arising from neonatal brachial plexus palsy. 55:24-30. 2000
The incidence of dementia in Canada. 55:66-73. 2000
Neurologic side effects in neuroleptic-naive patients treated with haloperidol or risperidone - Reply. 54:1543-1544. 2000
Treatment of acute disseminated encephalomyelitis with intravenous immunoglobulin. 54:1370-1372. 2000
Creatine monohydrate increases strength in patients with neuromuscular disease. 54:537-537. 2000
Major bleeding during anticoagulation after cerebral ischemia: patterns and risk factors. Stroke Prevention In Reversible Ischemia Trial (SPIRIT). European Atrial Fibrillation Trial (EAFT) study groups.. 53:1319-1327. 1999
Major bleeding during anticoagulation after cerebral ischemia. 53:1319-1319. 1999
Creatine monohydrate increases strength in patients with neuromuscular disease. 52:854-854. 1999
Neurologic side effects in neuroleptic-naive patients treated with haloperidol or risperidone. 52:782-782. 1999
Drugs acting at the glycine site on the NMDA receptor as cognitive enhancers in patients with Alzheimer's disease. 50:1195-1195. 1998
Temporal arteritis and polymyalgia rheumatica. 46:901-906. 1996
A randomized controlled trial of chronic vagus nerve stimulation for treatment of medically intractable seizures. 45:224-230. 1995
The Canadian Study of Health and Aging ^*. 44:2073-2073. 1994
Abnormal connectivity of the visual pathways in human albinos demonstrated by susceptibility‐sensitized MRI. 44:1921-1921. 1994
Heat shock protein immunoreactivity in CSF. 44:1644-1644. 1994
Variable distribution of mutant mitochondria1 DNAs (tRNA ^Leu[3243]) in tissues of symptomatic relatives with MELAS. 43:1586-1586. 1993
Clinical neurology as data for basic neuroscience. 43:859-859. 1993
Denervation in paraplegia. 42:2306-2306. 1992
Cognitive neuroanatomy. 42:709-709. 1992
Electrophysiologic changes in lumbar spinal cord after cervical cord injury. 42:623-623. 1992
Cholecystokinin and somatostatin in Alzheimer's disease postmortem cerebral cortex. 41:716-719. 1991
Substance P‐like immunoreactivity is reduced in Alzheimer's disease cerebral cortex. 37:1205-1205. 1987
Oxytocin in Alzheimer's disease. 37:1001-1001. 1987
Neuronal antibodies and cognitive function in systemic lupus erythematosus. 37:464-464. 1987
Acute “axonal” Guillain‐Barré polyneuropathy. 37:357-357. 1987
CSF vasopressin concentration is reduced in Alzheimer's disease. 36:1133-1133. 1986
CSF somatostatin‐like immunoreactivity in dementia. 36:294-294. 1986
Entrapment of the posterior cutaneous nerve of the arm. 35:1677-1677. 1985
MRI and the study of aphasia. 35:861-861. 1985
Dementia after surgery for cerebellar stroke. 35:568-568. 1985
Low serum 24,25 dihydroxyvitamin D in Duchenne muscular dystrophy.. 34:1192-1196. 1984
The anatomic basis of delusions after right cerebral infarction. 34:577-577. 1984
The human jaw jerk. 31:632-632. 1981
Light‐stimulus‐evoked blink reflex Methods, normal values, relation to other blink reflexes, and observations in multiple sclerosis. 31:272-272. 1981
Myotonic muscular dystrophy. 29:791-791. 1979
The muscular pain‐fasciculation syndrome. 28:1105-1105. 1978
Ban proposed on cerebeilar electricaI stimulation. 27:996-996. 1977
Epileptogenic action of intraventricularly injected antimelatonin antibody. 27:567-567. 1977
Prevention of venous thrombosis in patients with intracranial disease by intermittent pneumatic compression of the calf. 27:435-435. 1977
The effect of a peripheral decarboxylase inhibitor (carbidopa) on monoamine and neuroendocrine function in man. 27:443-443. 1977
The effect of ACTH treatment on lymphocyte subpopulations in patients with myasthenia gravis. 26:915-915. 1976
Studies of hippocampectomy in the monkey, baboon, and cat. 13:1031-1031. 1963

Neurology Journal

Overview

publication venue for

has subject area

Identity

International Standard Serial Number (ISSN)

Electronic International Standard Serial Number (EISSN)